Benuvia Manufacturing Institutes Senior Advisory Board
Valeria Coscia, Ph.D. , Bill DuBay, Ph.D., Paul Evans, and Mike Wittmann, Ph.D. will strategically advise Benuvia Manufacturing, a growing, privately held company
News provided by
Share this article
Share this article
ROUND ROCK, Texas, Jan. 14, 2021 /PRNewswire/ Benuvia Manufacturing, Inc, a leading CDMO providing small molecule active pharmaceutical ingredients, formulation and drug product manufacturing from preclinical to commercial scale, today announced the formation and appointment of a Senior Advisory Board. The members of the Senior Advisory Board bring more than 80 years of pharmaceutical and business experience.
Valeria Coscia, Ph.D., Bill DuBay, Ph.D., Paul Evans and Mike Wittmann, Ph.D. bring a wide variety of expertise and talent to this inaugural board.
A selection of meth seized by the Pennington County Sheriff s Office s narcotics enforcement team in South Dakota.
Pennington County Sheriff s Office via AP
As rates of methamphetamine overdose soar in the United States, one of the biggest challenges for both people who use stimulants and clinicians is that there are no approved treatments for this type of addiction unlike the three medications authorized to treat opioid use disorders.
But in a new study, researchers found that a combination of two existing drugs one, a treatment for opioid addiction, and the other, an antidepressant can help some people who use methamphetamine regularly cut back. In a clinical trial, the researchers reported Wednesday, 13.6% of participants treated with the two drugs had repeated urine tests free of methamphetamine, compared to just 2.5% of those who were given placebos.
Ginny Hamilton (Editorial Team) | January 11, 2021
The COVID-19 pandemic reset business expectations in a monumental way – and elevated the role of CIOs who led strong responses to the immediate crisis. Those CIOs now find themselves with amplified influence, according to new research from Harvard Business Review Analytic Services.
The crisis, for all of its challenges, shattered previous notions of what was and wasn t possible, liberating CIOs to do things in new ways.
“The crisis, for all of its challenges, shattered previous notions of what was and wasn’t possible, liberating CIOs to do things in new ways. Organizations in general, and CIOs specifically, are operating under new rules for the next normal,” the report states.